Polycystic kidney disease (PKD) is a genetic disorder characterized by

Polycystic kidney disease (PKD) is a genetic disorder characterized by the growth of numerous cysts in the kidneys. These cysts are filled with fluid. If too many cysts grow or if they get too big, the kidneys can become damaged. PKD cysts can slowly replace much of the kidneys, reducing kidney function and leading to kidney failure.
PKD Treatment is an autosomal recessive disease, which means both copies of the PKHD1 gene have to be mutated for the disease to develop. If there is one faulty copy of the gene, a person carries the mutation without developing any symptoms. However, if two people who are both carriers have a baby, there is a one in four chance the baby will develop PKD.
PKD Treatment affects an estimated 27 million adults in the United States, and is associated with significantly increased risk of cardiovascular disease and stroke. Patients should be assessed annually to determine whether they are at increased risk of developing chronic kidney disease based on clinical and sociodemographic factors. Diabetes mellitus, hypertension, and older age are the primary risk factors that warrant screening. Other risk factors include cardiovascular disease,
The main job of each kidney is to filter waste and excess water out of your blood to make urine. They help maintain the body's chemical balance, control blood pressure and make hormones. Damaged kidneys can cause waste to build up in your body as well as other health problems. 
There is currently no cure for PKD.
PKD Treatment focuses on the condition's associated symptoms and any complications that may occur, such as kidney disease and high blood pressure.
In severe cases of ARPKD, symptoms may be present before birth or at birth and the newborn baby will usually need to be admitted to an intensive care unit so their breathing can be assisted with a ventilator.

http://www.sjzkidneyhospital.com/tags.php?/PKD+Treatment/